Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae

Stephanie Smith1, Ji‐Young Hwang2, Soma Banerjee2, Anju Majeed2, Amitabha Gupta2, Kyungjaem Myung2
1Genome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Bethesda, MD 20892 USA
2Genome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Bethesda, MD 20892

Tóm tắt

Different types of gross chromosomal rearrangements (GCRs), including translocations, interstitial deletions, terminal deletions with de novo telomere additions, and chromosome fusions, are observed in many cancers. Multiple pathways, such as S-phase checkpoints, DNA replication, recombination, chromatin remodeling, and telomere maintenance that suppress GCRs have been identified. To experimentally expand our knowledge of other pathway(s) that suppress GCRs, we developed a generally applicable genome-wide screening method. In this screen, we identified 10 genes ( ALO1, CDC50, CSM2, ELG1, ESC1, MMS4, RAD5, RAD18, TSA1 , and UFO1 ) that encode proteins functioning in the suppression of GCRs. Moreover, the breakpoint junctions of GCRs from these GCR mutator mutants were determined with modified breakpoint-mapping methods. We also identified nine genes ( AKR1, BFR1, HTZ1, IES6, NPL6, RPL13B, RPL27A, RPL35A , and SHU2 ) whose mutations generated growth defects with the pif1 Δ mutation. In addition, we found that some of these mutations changed the telomere size.

Từ khóa


Tài liệu tham khảo

10.1101/gad.10.12.1433

10.1038/25292

10.1016/S0079-6603(08)60723-0

10.1016/0092-8674(92)90586-2

10.1073/pnas.0334858100

10.1038/75985

10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T

10.1038/2524

10.1002/cyto.990190104

10.1007/s004390050626

10.1016/S0027-5107(99)00115-3

10.1126/science.1075277

10.1016/S1568-7864(02)00216-1

10.1073/pnas.1232239100

10.1101/gad.1011002

10.1016/S1097-2765(02)00513-0

10.1101/gad.1089203

10.1038/85798

10.1038/35082608

10.1126/science.289.5480.771

10.1016/0092-8674(94)90179-1

10.1093/genetics/121.4.659

10.1016/0168-9525(93)90042-G

10.1126/science.1056072

10.1016/S0092-8674(01)00227-6

10.1126/science.1065810

10.1126/science.1083413

10.1093/genetics/159.4.1449

10.1073/pnas.1633757100

10.1093/emboj/cdg406

10.1016/S0960-9822(03)00578-5

10.1016/S0921-8777(01)00091-X

10.1007/s004380050689

10.1093/genetics/157.1.103

10.1016/S0092-8674(01)00536-0

10.1046/j.1365-2958.1998.01133.x

10.1074/jbc.M106846200

10.1073/pnas.2035018100

10.1002/1097-0061(200102)18:3<195::AID-YEA660>3.0.CO;2-L

10.1016/S0960-9822(01)00274-3

10.1128/MCB.22.23.8292-8301.2002

10.1074/jbc.M308671200

10.1073/pnas.062702199

10.1038/nrc970

10.1073/pnas.1934561100

10.1006/geno.2000.6179

10.1016/S0304-3835(00)00434-1

Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W., Park, I. A. & Chae, H. Z. (2001) Anticancer Res. 21, 2085-2090.11497302

10.1128/MCB.23.2.474-481.2003

10.1016/S0888-7543(03)00121-6

10.1038/nature01819